VRDN
Viridian Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD16.35
+0.48 (+3.02%)
Rating:C-
Company Profile
CEO
Stephen F. Mahoney
IPO Date
2014-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$15.79
Prev. Close
$15.87
Day Low
$15.75
Day High
$16.40
52W Low
$13.18
52W High
$34.29
Market Cap
$1.47B
Volume
1.64M